Actinium Pharmaceuticals Inc (ATNM)
7.94
-0.18
(-2.22%)
USD |
NYAM |
Mar 27, 16:00
7.90
-0.04
(-0.50%)
After-Hours: 20:00
Actinium Pharmaceuticals Price: 7.94 for March 27, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
Mar 27, 2024 | 8.08 | 8.34 | 7.89 | 7.94 | 468542.0 |
Mar 26, 2024 | 8.77 | 9.05 | 8.00 | 8.12 | 566332.0 |
Mar 25, 2024 | 9.34 | 9.45 | 8.60 | 8.67 | 549323.0 |
Mar 22, 2024 | 9.15 | 9.860 | 8.88 | 9.20 | 1.780M |
Mar 21, 2024 | 8.70 | 9.30 | 8.63 | 9.11 | 1.690M |
Mar 20, 2024 | 8.20 | 8.70 | 7.90 | 8.60 | 1.088M |
Mar 19, 2024 | 7.60 | 8.50 | 7.30 | 8.21 | 2.036M |
Mar 18, 2024 | 6.98 | 6.98 | 6.35 | 6.54 | 259951.0 |
Mar 15, 2024 | 6.20 | 6.78 | 6.16 | 6.75 | 331867.0 |
Mar 14, 2024 | 6.73 | 6.87 | 6.22 | 6.27 | 194258.0 |
Mar 13, 2024 | 6.57 | 6.75 | 6.48 | 6.70 | 104131.0 |
Mar 12, 2024 | 6.81 | 7.00 | 6.58 | 6.59 | 151677.0 |
Mar 11, 2024 | 7.67 | 7.749 | 6.83 | 6.92 | 244376.0 |
Mar 08, 2024 | 7.61 | 8.03 | 7.51 | 7.65 | 174888.0 |
Mar 07, 2024 | 7.74 | 7.80 | 7.44 | 7.61 | 166392.0 |
Mar 06, 2024 | 7.88 | 8.06 | 7.69 | 7.76 | 90973.00 |
Mar 05, 2024 | 7.75 | 8.00 | 7.52 | 7.77 | 116037.0 |
Mar 04, 2024 | 8.50 | 8.50 | 7.72 | 7.88 | 263192.0 |
Mar 01, 2024 | 8.49 | 8.50 | 8.17 | 8.47 | 217579.0 |
Feb 29, 2024 | 8.49 | 8.78 | 8.21 | 8.53 | 256160.0 |
Feb 28, 2024 | 8.12 | 8.35 | 8.05 | 8.31 | 158645.0 |
Feb 27, 2024 | 8.50 | 8.66 | 7.82 | 8.27 | 462521.0 |
Feb 26, 2024 | 7.00 | 8.399 | 6.96 | 8.31 | 690914.0 |
Feb 23, 2024 | 7.04 | 7.170 | 6.52 | 6.86 | 215520.0 |
Feb 22, 2024 | 6.64 | 6.98 | 6.52 | 6.74 | 140556.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
4.02
Minimum
Nov 28 2023
18.00
Maximum
Aug 03 2020
7.808
Average
7.413
Median
Jun 27 2019
Price Benchmarks
Cellectar Biosciences Inc | 3.64 |
Bristol-Myers Squibb Co | 53.25 |
Perspective Therapeutics Inc | 1.20 |
Eli Lilly and Co | 778.18 |
CASI Pharmaceuticals Inc | 2.99 |
Price Related Metrics
PS Ratio | 196.93 |
Price to Book Value | 4.994 |
Earnings Yield | -24.31% |
Market Cap | 217.66M |